Ursprung des Netzwerks ersten Grades von Charon Spencer

EinheitArt der EinheitIndustrie
Public Company Pharmaceuticals: Major 17

Unternehmensgrafik - zweiten Grades

Beziehungen zu mehreren Unternehmen

Unternehmensverbindungen über das persönliche Netzwerk von Charon Spencer

UnternehmenSektorVerknüpfte PersonenHauptposition
BRISTOL-MYERS SQUIBB COMPANY Pharmaceuticals: Major

Mike Raab Raab

Corporate Officer/Principal

ELI LILLY AND COMPANY Pharmaceuticals: Major

Jan Lundberg

Chief Tech/Sci/R&D Officer

Biotechnology

William Bertrand

David Mott

General Counsel

Chief Executive Officer

REPLIGEN CORPORATION Pharmaceuticals: Major

Mike Raab Raab

Corporate Officer/Principal

ASTRAZENECA PLC Pharmaceuticals: Major

David Mott

Jan Lundberg

Corporate Officer/Principal

Chief Tech/Sci/R&D Officer

NOVAVAX, INC. Biotechnology

Richard Rodgers

David Mott

Director/Board Member

Director/Board Member

AMICUS THERAPEUTICS, INC. Pharmaceuticals: Major

Mike Raab Raab

Chairman

AEROCRINE AB Electronic Equipment/Instruments

Jan Lundberg

Founder

Packaged Software

Jan Lundberg

Director/Board Member

Pharmaceuticals: Generic

Jan Lundberg

Director/Board Member

REATA PHARMACEUTICALS, INC. Pharmaceuticals: Major

Geoffrey A. Block

Corporate Officer/Principal

Pharmaceuticals: Major

David Mott

Mike Raab Raab

Director/Board Member

Director/Board Member

Miscellaneous Commercial Services

David Mott

Jan Lundberg

Mike Raab Raab

Director/Board Member

Director/Board Member

Corporate Officer/Principal

HYPERION THERAPEUTICS INC Pharmaceuticals: Major

Mike Raab Raab

Director/Board Member

TESARO INC Pharmaceuticals: Major

Richard Rodgers

David Mott

Founder

Chairman

Biotechnology

Mike Raab Raab

Chairman

University of Pennsylvania College/University

Susan Rodriguez

David Rosenbaum

Graduate Degree

Undergraduate Degree

Miscellaneous Commercial Services

Richard Rodgers

Justin Renz

Corporate Officer/Principal

Corporate Officer/Principal

SAGIMET BIOSCIENCES INC. Pharmaceuticals: Major

Richard Rodgers

David Mott

Elizabeth Grammer

Director/Board Member

Chairman

Director/Board Member

EPIZYME, INC. Biotechnology

David Mott

Robert Bazemore

Chairman

Chief Executive Officer

Investment Managers

David Mott

Mike Raab Raab

Private Equity Investor

Private Equity Investor

Investment Managers

David Mott

Mike Raab Raab

Corporate Officer/Principal

Corporate Officer/Principal

ADAPTIMMUNE THERAPEUTICS PLC Biotechnology

William Bertrand

David Mott

Chief Operating Officer

Chairman

TEMPEST THERAPEUTICS, INC. Pharmaceuticals: Major

Mike Raab Raab

Chairman

Pharmaceuticals: Major

Mike Raab Raab

Corporate Officer/Principal

Biotechnology

Jan Lundberg

Director/Board Member

Biotechnology

Mike Raab Raab

Director/Board Member

Karolinska Institutet College/University

Jan Lundberg

Corporate Officer/Principal

Miscellaneous Commercial Services

Jan Lundberg

Director/Board Member

Miscellaneous Commercial Services

Jan Lundberg

President

THERACLION Medical Specialties

Geoffrey A. Block

Director/Board Member

Medical/Nursing Services

Geoffrey A. Block

Corporate Officer/Principal

Industrial Machinery

Jan Lundberg

Director/Board Member

Pharmaceuticals: Major

Jan Lundberg

Director/Board Member

Investment Managers

Jan Lundberg

Consultant / Advisor

ALZECURE PHARMA AB Biotechnology

Jan Lundberg

Director/Board Member

Pharmaceuticals: Major

Jan Lundberg

Director/Board Member

Pharmaceuticals: Major

Jan Lundberg

Director/Board Member

University of Gothenburg College/University

Jan Lundberg

Doctorate Degree

DePauw University College/University

Mike Raab Raab

Undergraduate Degree

Statistik

International

Vereinigte Staaten 39
Schweden 9
Vereinigtes Königreich 3
Frankreich 2

Sektoral

Health Technology 34
Commercial Services 5
Consumer Services 5
Finance 4
Health Services 3

Operativ

Director/Board Member 90
Corporate Officer/Principal 43
Independent Dir/Board Member 31
Chairman 19
Undergraduate Degree 14
  1. Börse
  2. Insiders
  3. Charon Spencer
  4. Unternehmensverbindungen
-40 % Zeitlich begrenztes Angebot: Unsere Abonnements führen Sie zu den besten Investitionen von morgen.
PROFITIEREN SIE JETZT